Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis

Tsuyoshi Shimo, Tohru Nakanishi, Takashi Nishida, Masahiro Asano, Akira Sasaki, Manabu Kanyama, Takuo Kuboki, Tomohiro Matsumura, Masaharu Takigawa

Research output: Contribution to journalArticlepeer-review

85 Citations (Scopus)


Connective tissue growth factor (CTGF) is a potent secreted signaling factor which functions in multiple stages of angiogenesis. In the present study, we examined the role of CTGF in tumor angiogenesis and made the following observations: (1) Histological analysis of human breast cancer (MDA231) cell and human fibrosarcoma (HT1080) cell xenografts in BALB/c nude mice showed a high level of neovascularization. Human squamous cell carcinoma (A431) xenografts induced only a low level of neovascularization. (2) CTGF mRNA was strongly expressed in MDA231 and in HT1080 cells in vivo and in vitro, but not in A431 cells. (3) CTGF protein was markedly produced in MDA231 cells and HT1080 cells and secreted into culture medium, and its production was greater during phases of growth rather than confluency. (4) Production of CTGF in bovine aorta endothelial cells was induced by CTGF, VEGF, bFGF and TGF-β. (5) Neovascularization induced by HT1080 cells or MDA231 cells on chicken chorioallantoic membrane was suppressed in the presence of neutralizing CTGF-specific polyclonal antibody. These results suggest that CTGF regulates progression in tumor angiogenesis and the release or secretion of CTGF from tumor cells is essential for the angiogenesis.

Original languageEnglish
Pages (from-to)315-322
Number of pages8
Issue number4
Publication statusPublished - 2001


  • Angiogenesis
  • Connective tissue growth factor
  • Neovascularization

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis'. Together they form a unique fingerprint.

Cite this